The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Precision Medicine Market Research Report 2024

Global Precision Medicine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1411060

No of Pages : 99

Synopsis

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

The global Precision Medicine market was valued at US$ 119040 million in 2023 and is anticipated to reach US$ 227820 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.

The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.

Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.

Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.

This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.

Report Scope

The Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Johnson & Johnson
  • Roche
  • Labcorp
  • Abbott Laboratories
  • Novartis
  • Illumina
  • GE Healthcare
  • Intel Corporation
  • Biomrieux Sa
  • Cepheid
  • IBM
  • Qiagen
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Almac Group
  • Healthcore

Segment by Type

  • Diagnostics
  • Therapies
  • Segment by Application
  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Market by Application
1.3.1 Global Precision Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Medicine Market Perspective (2019-2030)
2.2 Precision Medicine Growth Trends by Region
2.2.1 Global Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Precision Medicine Historic Market Size by Region (2019-2024)
2.2.3 Precision Medicine Forecasted Market Size by Region (2025-2030)
2.3 Precision Medicine Market Dynamics
2.3.1 Precision Medicine Industry Trends
2.3.2 Precision Medicine Market Drivers
2.3.3 Precision Medicine Market Challenges
2.3.4 Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Medicine Players by Revenue
3.1.1 Global Top Precision Medicine Players by Revenue (2019-2024)
3.1.2 Global Precision Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Medicine Revenue
3.4 Global Precision Medicine Market Concentration Ratio
3.4.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Revenue in 2023
3.5 Precision Medicine Key Players Head office and Area Served
3.6 Key Players Precision Medicine Product Solution and Service
3.7 Date of Enter into Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Medicine Breakdown Data by Type
4.1 Global Precision Medicine Historic Market Size by Type (2019-2024)
4.2 Global Precision Medicine Forecasted Market Size by Type (2025-2030)
5 Precision Medicine Breakdown Data by Application
5.1 Global Precision Medicine Historic Market Size by Application (2019-2024)
5.2 Global Precision Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Precision Medicine Market Size (2019-2030)
6.2 North America Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Precision Medicine Market Size by Country (2019-2024)
6.4 North America Precision Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Medicine Market Size (2019-2030)
7.2 Europe Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Precision Medicine Market Size by Country (2019-2024)
7.4 Europe Precision Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Market Size (2019-2030)
8.2 Asia-Pacific Precision Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Precision Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Precision Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Medicine Market Size (2019-2030)
9.2 Latin America Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Precision Medicine Market Size by Country (2019-2024)
9.4 Latin America Precision Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Market Size (2019-2030)
10.2 Middle East & Africa Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Precision Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Precision Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Precision Medicine Introduction
11.1.4 Johnson & Johnson Revenue in Precision Medicine Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Precision Medicine Introduction
11.2.4 Roche Revenue in Precision Medicine Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Precision Medicine Introduction
11.3.4 Labcorp Revenue in Precision Medicine Business (2019-2024)
11.3.5 Labcorp Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Precision Medicine Introduction
11.4.4 Abbott Laboratories Revenue in Precision Medicine Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Precision Medicine Introduction
11.5.4 Novartis Revenue in Precision Medicine Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Illumina
11.6.1 Illumina Company Detail
11.6.2 Illumina Business Overview
11.6.3 Illumina Precision Medicine Introduction
11.6.4 Illumina Revenue in Precision Medicine Business (2019-2024)
11.6.5 Illumina Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Precision Medicine Introduction
11.7.4 GE Healthcare Revenue in Precision Medicine Business (2019-2024)
11.7.5 GE Healthcare Recent Development
11.8 Intel Corporation
11.8.1 Intel Corporation Company Detail
11.8.2 Intel Corporation Business Overview
11.8.3 Intel Corporation Precision Medicine Introduction
11.8.4 Intel Corporation Revenue in Precision Medicine Business (2019-2024)
11.8.5 Intel Corporation Recent Development
11.9 Biomrieux Sa
11.9.1 Biomrieux Sa Company Detail
11.9.2 Biomrieux Sa Business Overview
11.9.3 Biomrieux Sa Precision Medicine Introduction
11.9.4 Biomrieux Sa Revenue in Precision Medicine Business (2019-2024)
11.9.5 Biomrieux Sa Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Precision Medicine Introduction
11.10.4 Cepheid Revenue in Precision Medicine Business (2019-2024)
11.10.5 Cepheid Recent Development
11.11 IBM
11.11.1 IBM Company Detail
11.11.2 IBM Business Overview
11.11.3 IBM Precision Medicine Introduction
11.11.4 IBM Revenue in Precision Medicine Business (2019-2024)
11.11.5 IBM Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Precision Medicine Introduction
11.12.4 Qiagen Revenue in Precision Medicine Business (2019-2024)
11.12.5 Qiagen Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Precision Medicine Introduction
11.13.4 Thermo Fisher Scientific Revenue in Precision Medicine Business (2019-2024)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Randox Laboratories
11.14.1 Randox Laboratories Company Detail
11.14.2 Randox Laboratories Business Overview
11.14.3 Randox Laboratories Precision Medicine Introduction
11.14.4 Randox Laboratories Revenue in Precision Medicine Business (2019-2024)
11.14.5 Randox Laboratories Recent Development
11.15 Almac Group
11.15.1 Almac Group Company Detail
11.15.2 Almac Group Business Overview
11.15.3 Almac Group Precision Medicine Introduction
11.15.4 Almac Group Revenue in Precision Medicine Business (2019-2024)
11.15.5 Almac Group Recent Development
11.16 Healthcore
11.16.1 Healthcore Company Detail
11.16.2 Healthcore Business Overview
11.16.3 Healthcore Precision Medicine Introduction
11.16.4 Healthcore Revenue in Precision Medicine Business (2019-2024)
11.16.5 Healthcore Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’